This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for one thousand capsules of tamsulosin HCL 0.4 mg at a firm fixed price of one hundred sixty-eight dollars. To be completed by December 2, 2022, this order is likely placed against DLA's Prime Vendor contract to supply various pharmaceutical products to military treatment facilities. No set-aside designation was applied. As the DLA manages the global supply chain for the Department of Defense, this order will support medical readiness by providing proven generic medications to servicemembers receiving care through DLA-supported clinics.
Generated 1/3/24, 2:36 AM